Bio-printing of living cells for regenerative medicine

This section outlines the eligibility criteria for applicants, the geographical scope of the program, and its core objectives in advancing regenerative medicine. The program targets a diverse range of entities and individuals engaged in biomedical research and technology development across the European Union and the United States, encouraging collaborative, multidisciplinary approaches to address critical health needs.

This section details the specific types of projects and thematic areas supported by the program, emphasizing research and innovation in regenerative medicine, alongside eligible project stages. The focus is on advancing bio-printing technologies to overcome current limitations and translate cutting-edge research into clinical applications for improved health outcomes.

This section provides an overview of the financial support available through this Horizon Europe call, including the type of financial instrument and the funding limits per project. The program offers significant grant funding to foster advanced research in bio-printing and regenerative medicine.

This section highlights the essential conditions and specific provisions that applicants and beneficiaries must adhere to throughout the application and project implementation phases. Key aspects include application rules, collaboration expectations, and other critical regulatory and ethical considerations.

This section outlines the application process, from submission to evaluation and award notification. It provides key dates and details on how proposals are assessed by independent experts.

This section identifies the foundational legal and policy documents governing the funding program, providing transparency on its mandate and operational framework.